In Estonia, researchers are investigating methods to support the early detection of prostate cancer in a way that is both reasonable and efficient for patients and the healthcare system. A new risk-based approach to screening could help to prevent unnecessary prostate biopsies, which are often stressful and invasive for patients. Prostate cancer is the most commonly diagnosed malignant tumor in men, but early detection can lead to effective treatment, highlighting the importance of improving screening methods.

The Health Development Institute (TAI) has begun assessing the feasibility of a risk-based screening approach in collaboration with other Estonian healthcare institutions. This method takes into account individual risk factors for men, aiming to enhance the effectiveness of early detection while minimizing the risk of overdiagnosis and unnecessary treatment procedures. Such an approach not only has the potential to improve patient outcomes but also to optimize the allocation of healthcare resources.

Epidemiologist Mari-Liis Väli from TAI emphasized the importance of making screening a simpler and less daunting experience for patients. By alleviating the fears associated with screening and ensuring it is tailored to individual risk profiles, there is potential to increase participation in screening programs, ultimately leading to better health outcomes for men at risk of prostate cancer.